Provided by Tiger Trade Technology Pte. Ltd.

KT Corp

19.67
-0.0100-0.05%
Post-market: 19.670.00000.00%19:30 EDT
Volume:933.30K
Turnover:18.41M
Market Cap:9.48B
PE:11.35
High:19.96
Open:19.79
Low:19.62
Close:19.68
52wk High:24.58
52wk Low:17.13
Shares:482.19M
Float Shares:422.00M
Volume Ratio:0.77
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.73
EPS(LYR):2.46
ROE:7.15%
ROA:2.69%
PB:0.66
PE(LYR):7.98

Loading ...

KT Declares Quarterly Cash Dividend Payout

MT Newswires Live
·
Jul 14

SK Telecom and KT to Lead 17.2 Billion Won Government-Backed Hyper-AI Networks Project

MT Newswires Live
·
Jul 14

Market Chatter: KT to Invest KRW18 Trillion to Transform into AI Platform Company

MT Newswires Live
·
Jul 07

Kymera Therapeutics (KYMR) Is Up 16.7% After KT-621 Trial Acceleration And Index Additions Has The Bull Case Changed?

Simply Wall St.
·
Jul 01

Kymera Therapeutics Advances KT-621 Development With Phase 2b Enrollment Completion

MT Newswires Live
·
Jun 25

Korea Exchange Activated the KOSPI "Sidecar" Temporary Trading-Halt Mechanism. SK Hynix Soared 10%; Samsung Electronics Jumped over 5%

Tiger Newspress
·
Jun 25

Korean Chip Stocks Hit by Profit-Taking; Indexes Trigger Circuit Breakers

Tiger Newspress
·
Jun 23

Why Kymera Therapeutics (KYMR) Is Up 16.6% After Positive KT-621 Phase 1 Japanese Data

Simply Wall St.
·
Jun 16

Kintor Pharma-B Reports Positive Interim Safety Data for KT-939 and Initiates New Cosmetic Ingredient Registration

Stock News
·
Jun 10

KT Corporation Details April–May 2026 Share Buybacks Under Repurchase Trust

TIPRANKS
·
Jun 10

Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses

GlobeNewswire
·
Jun 08

Korea Exchange Triggered a Market-Wide Circuit Breaker After the KOSPI Fell 8%, Samsung and SK Hynix Each Down 10%

Tiger Newspress
·
Jun 08

KT Corporation Posts Lower Q1 2026 Profit as Auditor Confirms Compliance with Korean IFRS

TIPRANKS
·
May 29

KT SAT Evolves into a 'Total Space Solution Provider' Presenting the Vision of "Space for Humanity"

prnewswire
·
May 22

KT on Track for Lowest Close Since December 2025 -- Data Talk

Dow Jones
·
May 21

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

GlobeNewswire
·
May 15

KT Corp's Q1 Net Profit Plunges 31.5% Amid Data Breach Costs and High Base Effect

Deep News
·
May 13

KT's Net Income Declines 35% in Q1

MT Newswires Live
·
May 12

YKT Corp Sees 1H Net Y25.00M

Dow Jones
·
May 08

Earning Preview: KT Corp this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
May 06